• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌梗死后血栓形成活性升高:一项为期2年的随访研究。

Elevated thrombotic activity after myocardial infarction: A 2-year follow-up study.

作者信息

Martínez-Sales V, Vila V, Réganon E, Goberna M A, Ferrando F, Palencia M A, Aznar J

机构信息

Research Center, Department of Clinic Pathology, La Fe University Hospital, Valencia, Spain.

出版信息

Haemostasis. 1998 Nov-Dec;28(6):301-6. doi: 10.1159/000022446.

DOI:10.1159/000022446
PMID:10461012
Abstract

This study examines the evolution of the thrombotic activity in patients with myocardial infarction (MI) treated with aspirin (200 mg/day) for 2 years after MI. Plasma samples of 10 patients were collected at 7, 30, 60, 90, 120, 150, 180, 360 and 720 days. In all the samples we measured fibrinogen (Fg), high molecular weight Fg (HMW-Fg), fibrinopeptide A (FPA), prothrombin fragment 1+2 (F1+2), beta-thromboglobulin (beta-TG), von Willebrand factor (vWF), tissue factor (TF) and TF pathway inhibitor (TFPI). The plasma Fg, HMW-Fg, FPA, F1+2, beta-TG and vWF levels were significantly elevated in the patients at the beginning of the study as compared to the normal group. The 95% confidence intervals were Fg 277-333 mg/dl, HMW-Fg 200-244 mg/dl, FPA 5.3-16.5 ng/ml, F1+2 1.4-1.8 nmol/l, beta-TG 110-118 IU/ml and vWF 139-195%. At thirty days Fg and HMW-Fg returned to normal levels, whereas the increase in FPA and F1+2 levels persisted throughout the study. At 120 and 150 days, respectively, beta-TG and vWF returned to normal levels. The increase in thrombin generation and activity pointed to a persistent hypercoagulable state 2 years after MI. Plasma levels of TF and TFPI showed no statistically significant variations with respect to the normal values over the 2-year period studied. In conclusion, these results suggest a persistent generation and activity of thrombin and cellular activation in these patients after MI.

摘要

本研究考察了心肌梗死(MI)患者在心肌梗死后接受阿司匹林(200毫克/天)治疗2年期间血栓形成活性的演变情况。在第7、30、60、90、120、150、180、360和720天采集了10名患者的血浆样本。在所有样本中,我们检测了纤维蛋白原(Fg)、高分子量纤维蛋白原(HMW-Fg)、纤维蛋白肽A(FPA)、凝血酶原片段1+2(F1+2)、β-血小板球蛋白(β-TG)、血管性血友病因子(vWF)、组织因子(TF)和组织因子途径抑制剂(TFPI)。与正常组相比,研究开始时患者血浆中的Fg、HMW-Fg、FPA、F1+2、β-TG和vWF水平显著升高。95%置信区间为:Fg 277 - 333毫克/分升,HMW-Fg 200 - 244毫克/分升,FPA 5.3 - 16.5纳克/毫升,F1+2 1.4 - 1.8纳摩尔/升,β-TG 110 - 118国际单位/毫升,vWF 139 - 195%。在第30天时,Fg和HMW-Fg恢复到正常水平,而FPA和F1+2水平的升高在整个研究过程中持续存在。分别在第120天和150天时,β-TG和vWF恢复到正常水平。凝血酶生成和活性的增加表明心肌梗死后2年存在持续的高凝状态。在研究的2年期间,血浆TF和TFPI水平与正常值相比无统计学显著差异。总之,这些结果表明心肌梗死后这些患者存在凝血酶的持续生成和活性以及细胞激活。

相似文献

1
Elevated thrombotic activity after myocardial infarction: A 2-year follow-up study.心肌梗死后血栓形成活性升高:一项为期2年的随访研究。
Haemostasis. 1998 Nov-Dec;28(6):301-6. doi: 10.1159/000022446.
2
Persistent activation of coagulation mechanism in unstable angina and myocardial infarction.不稳定型心绞痛和心肌梗死中凝血机制的持续激活。
Circulation. 1994 Jul;90(1):61-8. doi: 10.1161/01.cir.90.1.61.
3
Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction.急性心肌梗死中循环微粒上的组织因子途径抑制剂
Thromb Haemost. 2005 Jan;93(1):35-9. doi: 10.1160/TH04-06-0393.
4
Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin.
Am Heart J. 1986 Aug;112(2):285-90. doi: 10.1016/0002-8703(86)90263-2.
5
Plasma fibrinopeptide A and beta-thromboglobulin in patients with chest pain.
Thromb Haemost. 1983 Aug 30;50(2):541-2.
6
Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.缺血性心脏病患者体内组织因子及组织因子途径抑制物循环水平升高。
Thromb Haemost. 1998 Mar;79(3):495-9.
7
Studies on the functionality of newly synthesized fibrinogen after treatment of acute myocardial infarction with streptokinase, increase in the rate of fibrinopeptide release.用链激酶治疗急性心肌梗死后新合成纤维蛋白原的功能研究,纤维蛋白肽释放速率增加。
Thromb Haemost. 1993 Dec 20;70(6):978-83.
8
[Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].[纤维蛋白肽A作为血栓性疾病凝血分析指标的意义]
Hokkaido Igaku Zasshi. 1982 May;57(3):351-63.
9
[Beta-thromboglobulin and fibrinopeptide A in acute myocardial infarction].
Quad Sclavo Diagn. 1985 Jun;21(2):173-81.
10
Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction.心绞痛和急性心肌梗死患者的纤维蛋白肽A和β-血小板球蛋白
Am Heart J. 1984 Jan;107(1):39-45. doi: 10.1016/0002-8703(84)90131-5.

引用本文的文献

1
ImpaCt of aspirin regimen on THrombin generation in diabEtic patients with acute coronary syndrome: CARTHaGE-ACS trial.阿司匹林方案对急性冠脉综合征合并糖尿病患者凝血酶生成的影响:CART-HAGE-ACS 试验。
Eur J Clin Pharmacol. 2021 Apr;77(4):517-526. doi: 10.1007/s00228-020-02969-y. Epub 2020 Aug 6.
2
Duration of dual antiplatelet therapy in acute coronary syndrome.急性冠状动脉综合征中双重抗血小板治疗的持续时间。
Heart. 2017 Apr;103(8):573-580. doi: 10.1136/heartjnl-2016-309871. Epub 2017 Mar 1.
3
Thrombin Generation and Atherothrombosis: What Does the Evidence Indicate?
凝血酶生成与动脉粥样硬化血栓形成:证据表明了什么?
J Am Heart Assoc. 2016 Aug 8;5(8):e003553. doi: 10.1161/JAHA.116.003553.
4
Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study.西酞普兰治疗合并重度抑郁症和冠状动脉疾病患者的血小板及内皮活性:加拿大抗抑郁药与心理治疗疗效随机评估心脏试验(CREATE)生物标志物子研究
J Thromb Thrombolysis. 2009 Jan;27(1):48-56. doi: 10.1007/s11239-007-0189-3. Epub 2008 Jan 11.
5
Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study--rationale, design, and methodological issues.了解运动和抗抑郁治疗对抑郁症合并心脏病患者的预后益处:UPBEAT研究——原理、设计及方法学问题
Clin Trials. 2007;4(5):548-59. doi: 10.1177/1740774507083388.